Beurs gesloten -
Hong Kong S.E.
10:08:11 08-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
36,4
HKD
|
-2,28%
|
|
+2,68%
|
-54,19%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
149.934
|
326.828
|
347.115
|
236.612
|
215.748
|
126.105
|
-
|
-
|
Bedrijfswaarde
1 |
147.283
|
319.817
|
342.141
|
233.509
|
206.634
|
115.945
|
110.192
|
103.578
|
K/w-verhouding
|
82,2
x
|
108
x
|
68,5
x
|
28,7
x
|
22,5
x
|
13,7
x
|
11,3
x
|
10,6
x
|
Dividendrendement
|
0,37%
|
0,27%
|
0,44%
|
1,1%
|
1,35%
|
2,2%
|
2,39%
|
2,51%
|
Marktkapitalisatie/omzet
|
11,6
x
|
19,8
x
|
15,2
x
|
6,01
x
|
5,35
x
|
3,19
x
|
2,73
x
|
2,54
x
|
Bedrijfswaarde/omzet
|
11,4
x
|
19,3
x
|
14,9
x
|
5,93
x
|
5,12
x
|
2,93
x
|
2,38
x
|
2,09
x
|
Bedrijfswaarde/EBITDA
|
42,7
x
|
73,6
x
|
46,8
x
|
18,9
x
|
14,6
x
|
8,47
x
|
6,75
x
|
6,23
x
|
Bedrijfswaarde/FCF
|
566
x
|
336
x
|
-146
x
|
246
x
|
26,2
x
|
15,9
x
|
12,5
x
|
5,77
x
|
FCF Yield
|
0,18%
|
0,3%
|
-0,69%
|
0,41%
|
3,82%
|
6,27%
|
8%
|
17,3%
|
Price to Book
|
8,79
x
|
10,1
x
|
9,11
x
|
5,15
x
|
3,92
x
|
2,11
x
|
1,82
x
|
1,64
x
|
Aantal aandelen (in duizenden)
|
2.752.159
|
2.930.032
|
2.955.700
|
2.960.507
|
2.968.761
|
2.916.822
|
-
|
-
|
Referentieprijs
2 |
54,83
|
112,3
|
118,6
|
81,00
|
72,76
|
44,71
|
44,71
|
44,71
|
Datum van publicatie
|
24/03/20
|
5/03/21
|
15/02/22
|
20/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
12.872
|
16.535
|
22.902
|
39.355
|
40.341
|
39.525
|
46.232
|
49.571
|
EBITDA
1 |
3.449
|
4.348
|
7.308
|
12.370
|
14.194
|
13.695
|
16.324
|
16.639
|
Bedrijfsresultaat (EBIT)
1 |
2.486
|
3.656
|
6.038
|
10.652
|
11.872
|
11.668
|
13.750
|
13.388
|
Operationele Marge
|
19,31%
|
22,11%
|
26,36%
|
27,07%
|
29,43%
|
29,52%
|
29,74%
|
27,01%
|
Resultaat voor belastingen (EBT)
1 |
2.337
|
3.369
|
6.016
|
10.618
|
11.832
|
11.691
|
14.002
|
14.041
|
Nettowinst (verlies)
1 |
1.855
|
2.960
|
5.097
|
8.814
|
10.690
|
9.607
|
11.505
|
11.679
|
Nettomarge
|
14,41%
|
17,9%
|
22,26%
|
22,4%
|
26,5%
|
24,31%
|
24,89%
|
23,56%
|
WPA
2 |
0,6667
|
1,042
|
1,730
|
2,820
|
3,240
|
3,269
|
3,945
|
4,237
|
Free Cash Flow
1 |
260,3
|
951,3
|
-2.345
|
948
|
7.886
|
7.270
|
8.817
|
17.939
|
FCF-marge
|
2,02%
|
5,75%
|
-10,24%
|
2,41%
|
19,55%
|
18,39%
|
19,07%
|
36,19%
|
Kasstroomconversie (ebitda)
|
7,55%
|
21,88%
|
-
|
7,66%
|
55,56%
|
53,09%
|
54,01%
|
107,82%
|
Kasstroomconversie (nettowinst)
|
14,03%
|
32,14%
|
-
|
10,76%
|
73,77%
|
75,67%
|
76,64%
|
153,61%
|
Dividend per aandeel
2 |
0,2006
|
0,3025
|
0,5174
|
0,8927
|
0,9834
|
0,9843
|
1,068
|
1,122
|
Datum van publicatie
|
24/03/20
|
5/03/21
|
15/02/22
|
20/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019 S2
|
2020 S2
|
2021 S1
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
6.978
|
9.304
|
10.537
|
6.381
|
21.849
|
8.474
|
-
|
17.756
|
10.638
|
10.960
|
21.598
|
8.964
|
9.908
|
18.871
|
10.670
|
10.799
|
21.470
|
7.982
|
9.304
|
17.286
|
10.161
|
12.621
|
22.781
|
9.920
|
10.964
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
1.725
|
2.955
|
1.522
|
3.142
|
2.224
|
2.978
|
5.202
|
2.728
|
3.453
|
6.181
|
-
|
3.797
|
6.412
|
3.395
|
2.065
|
6.877
|
2.325
|
2.809
|
4.718
|
2.774
|
3.545
|
6.319
|
-
|
-
|
Operationele Marge
|
-
|
18,54%
|
28,04%
|
23,85%
|
14,38%
|
26,24%
|
-
|
29,29%
|
25,65%
|
31,51%
|
28,62%
|
-
|
38,33%
|
33,98%
|
31,82%
|
19,12%
|
32,03%
|
29,13%
|
30,19%
|
27,3%
|
27,3%
|
28,09%
|
27,74%
|
-
|
-
|
Resultaat voor belastingen (EBT)
1 |
-
|
1.447
|
-
|
5.587
|
-
|
1.999
|
-
|
-
|
-
|
1.799
|
5.078
|
2.609
|
3.786
|
6.395
|
3.387
|
2.050
|
6.534
|
2.297
|
2.928
|
-
|
3.285
|
3.670
|
-
|
-
|
-
|
Nettowinst (verlies)
1 |
-
|
1.243
|
-
|
1.535
|
4.830
|
1.643
|
2.993
|
-
|
2.742
|
1.436
|
4.178
|
2.168
|
3.145
|
5.313
|
2.763
|
2.614
|
5.377
|
1.942
|
2.396
|
-
|
2.716
|
3.012
|
-
|
-
|
-
|
Nettomarge
|
-
|
13,36%
|
-
|
24,05%
|
22,1%
|
19,39%
|
-
|
-
|
25,78%
|
13,1%
|
19,34%
|
24,19%
|
31,74%
|
28,15%
|
25,9%
|
24,2%
|
25,05%
|
24,33%
|
25,75%
|
-
|
26,73%
|
23,87%
|
-
|
-
|
-
|
WPA
2 |
-
|
-
|
-
|
0,5200
|
-
|
0,5300
|
0,9500
|
-
|
0,8200
|
0,5200
|
-
|
0,7200
|
1,070
|
-
|
0,9400
|
0,5100
|
-
|
0,6600
|
0,8000
|
-
|
0,8600
|
1,100
|
-
|
0,7100
|
1,260
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
24/03/20
|
5/03/21
|
12/08/21
|
15/02/22
|
15/02/22
|
25/04/22
|
26/07/22
|
26/07/22
|
26/10/22
|
20/03/23
|
20/03/23
|
24/04/23
|
31/07/23
|
31/07/23
|
30/10/23
|
18/03/24
|
18/03/24
|
29/04/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
638
|
7.011
|
4.974
|
3.103
|
9.115
|
10.160
|
15.913
|
22.528
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
260
|
951
|
-2.345
|
948
|
7.886
|
7.270
|
8.817
|
17.939
|
ROE (netto-inkomsten/eigen vermogen)
|
10,6%
|
11,9%
|
14,4%
|
20,6%
|
19%
|
15,9%
|
16,3%
|
15,5%
|
ROA (netto-inkomsten/totale activa)
|
7,15%
|
7,84%
|
10,1%
|
15,2%
|
15,5%
|
12,6%
|
12,7%
|
12,6%
|
Totale activa
1 |
25.952
|
37.763
|
50.709
|
57.966
|
69.180
|
76.438
|
90.850
|
92.927
|
Nettoactief per aandeel
2 |
6,240
|
11,10
|
13,00
|
15,70
|
18,60
|
21,20
|
24,50
|
27,30
|
Cashflow per aandeel
2 |
1,050
|
1,360
|
1,560
|
3,590
|
4,510
|
4,140
|
4,640
|
5,220
|
Capex
1 |
2.269
|
3.022
|
6.934
|
9.668
|
5.500
|
5.720
|
5.436
|
4.996
|
Capex/omzet
|
17,63%
|
18,28%
|
30,28%
|
24,57%
|
13,63%
|
14,47%
|
11,76%
|
10,08%
|
Datum van publicatie
|
24/03/20
|
5/03/21
|
15/02/22
|
20/03/23
|
18/03/24
|
-
|
-
|
-
|
Laatste slotkoers
44,71
CNY Gemiddelde koersdoel
68,82
CNY Spread / Gemiddelde doel +53,93% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +4,14% | 106 mld. | | +7,02% | 23,47 mld. | | -14,75% | 21,9 mld. | | -7,05% | 18,77 mld. | | -9,80% | 16,78 mld. | | +5,63% | 14,41 mld. | | +34,72% | 12,86 mld. | | +325,52% | 8,78 mld. | | -25,34% | 8,37 mld. |
Biotherapeutische geneesmiddelen
|